12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · 03/02 17:05
Gainers
- Rallybio (NASDAQ:RLYB) shares moved upwards by 25.6% to $9.47 during Monday's regular session. The market value of their outstanding shares is at $39.8 million.
- Astrana Health (NASDAQ:ASTH) shares moved upwards by 24.44% to $25.3. The company's market cap stands at $1.0 billion. The company's, Q4 earnings came out today.
- Hyperliquid Strategies (NASDAQ:PURR) stock increased by 21.32% to $4.95. The company's market cap stands at $505.7 million.
- Rafael Holdings (NYSE:RFL) stock moved upwards by 20.86% to $1.53. The market value of their outstanding shares is at $65.7 million.
- Compugen (NASDAQ:CGEN) shares rose 20.44% to $2.18. The market value of their outstanding shares is at $169.2 million. As per the news, the Q4 earnings report came out today.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares increased by 19.44% to $0.12.
Losers
- Aardvark Therapeutics (NASDAQ:AARD) shares decreased by 55.4% to $5.58 during Monday's regular session. The market value of their outstanding shares is at $271.9 million.
- Pulmatrix (NASDAQ:PULM) shares decreased by 35.79% to $1.92. The market value of their outstanding shares is at $10.9 million. The company's, Q4 earnings came out 2 days ago.
- uniQure (NASDAQ:QURE) shares decreased by 35.13% to $10.14. The market value of their outstanding shares is at $973.6 million. The company's, Q4 earnings came out today.
- Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares declined by 29.32% to $4.63. The market value of their outstanding shares is at $11.9 million.
- BioAtla (NASDAQ:BCAB) shares decreased by 24.01% to $0.19. The market value of their outstanding shares is at $18.3 million.
- ClearPoint Neuro (NASDAQ:CLPT) shares fell 21.64% to $9.85. The market value of their outstanding shares is at $373.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.